|
Post by dgriffin on Feb 14, 2008 11:09:14 GMT -5
By Anna Boyd February 14th 2008 eFlux Media
The Food and Drug Administration plans to perform an inspection at the Chinese plant that manufactures Baxter International’s heparin medication, the blood thinner whose production was halted this week due to health concerns.
It has come to the Food and Drug Administration’s attention that the Chinese plant where Baxter International’s blood-thinning drug is produced has never been inspected by U. S. regulators, which makes this measure an immediate necessity.
“Preparations are being made to perform an inspection as soon as possible,” FDA spokeswoman Karen Riley told Reuters in an email.
Authorities have yet to determine whether the Chinese factory has had any part in the worrisome reports that have increased in number recently. About 350 people have fallen ill since the end of 2007, after being treated with heparin. Four persons died, the agency reported, although the link with heparin is unclear.
### Trouble is, we have no control over our purchase of drugs. I can't walk into CVS or send away to Caremark and specify "No Chinese, please." Which I would have done re Tiananmen Square, before the poison scares.
|
|